A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes

NPJ Breast Cancer. 2022 Jul 19;8(1):85. doi: 10.1038/s41523-022-00451-9.

Francesco Schettini^{1

2

3}, Fara Brasó-Maristany¹, Nicole M Kuderer⁴, Aleix Prat^{5

6

7

8}

¹ Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.
² Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
³ Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
⁴ Advanced Cancer Research Group, LLC, Kirkland, WA, USA.
⁵ Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. alprat@clinic.cat.
⁶ Translational Genomics and Targeted Therapies in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.
⁷ Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. alprat@clinic.cat.
⁸ Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain. alprat@clinic.cat.

No abstract available